Fineotex Chemical Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fineotex Chemical reported Q1 FY26 consolidated revenue of ~Rs. 13,707 lakhs, up ~14.4% quarter-on-quarter (QoQ) from ~Rs. 11,979 lakhs in Q4 FY25, but down ~3.4% year-on-year (YoY) from ~Rs. 14,190 lakhs in Q1 FY25. Consolidated profit after tax (PAT) grew ~24.3% QoQ to ~Rs. 2,503 lakhs but declined ~14.2% YoY. Operational EBITDA rose ~18.4% QoQ to ~Rs. 2,520 lakhs, with ROIC at ~30.7% and volume growth of ~14.7% QoQ. On a standalone basis, revenue fell ~7.8% YoY to ~Rs. 9,826 lakhs and PAT fell ~8.9% YoY to ~Rs. 1,989 lakhs. The company commissioned a new 3,00,000 sq ft manufacturing facility at Ambernath on time and within budget. The board approved the 22nd AGM for September 19, 2025, appointed Mr. Chetan Shah as an Independent Director and M/s. HSPN & Associates as Secretarial Auditor, and granted 58,797 additional stock options under the ESOP 2020. The statutory auditor issued an unqualified (clean) limited review report on both results.
Mixed near-term picture: sequential improvement in profitability and margins is encouraging, but the YoY decline in both revenue and PAT signals demand-side pressure. Successful commissioning of the new Ambernath plant adds meaningful capacity for future growth, which is the key positive for shareholders to watch in coming quarters.